I would add announcement of results from animal trials in the new indications is just as big if not bigger. I expect this announcement, in addition to the 3 positive Ph2's to truly highlight platform potential of NNZ-2591 and associated value to us and any potential acquirer.
- Forums
- ASX - By Stock
- NEU
- Ann: H1 2024 financial results
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.58%
!
$16.74

Ann: H1 2024 financial results, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.74 |
Change
0.260(1.58%) |
Mkt cap ! $2.097B |
Open | High | Low | Value | Volume |
$16.65 | $16.90 | $16.33 | $2.351M | 140.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 74 | $16.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.75 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 74 | 16.740 |
3 | 527 | 16.730 |
6 | 537 | 16.720 |
5 | 633 | 16.710 |
5 | 980 | 16.700 |
Price($) | Vol. | No. |
---|---|---|
16.760 | 40 | 1 |
16.770 | 273 | 4 |
16.780 | 432 | 7 |
16.790 | 414 | 6 |
16.800 | 1944 | 6 |
Last trade - 11.59am 29/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |